Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi

Blood (2021) 138 (Supplement 1): 2487.

https://doi.org/10.1182/blood-2021-150337

Published: 2021

Journal Articles

Definition and Validation of the New Elderly Prognostic Index (EPI) for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Geriatric and Clinical Assessment: Results of the Prospective "Elderly Project" on 1353 Patients By the Fondazione Italiana Linfomi

Blood (2019) 134 (Supplement_1): 398.

https://doi.org/10.1182/blood-2019-123027

Published: 2019

Journal Articles

The Elderly Project By the Fondazione Italiana Linfomi (FIL): A Prospective Multidimensional Assessment of Elderly Patients with Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 3049.

https://doi.org/10.1182/blood.V128.22.3049.3049

Published: 2016

Journal Articles

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD

Blood (2014) 124 (21): 499.

https://doi.org/10.1182/blood.V124.21.499.499

Published: 2014

Journal Articles

FDG-PET and Hodgkin Lymphoma: Are We Ready for a Functional Tumor Volume Definition?

Francesco Merli, MD, Stefano Luminari, MD, Chiara Coriani, MD, Paolo G Gobbi, Prof, Federica Fioroni, Dr, Isabella Capodanno, MD, Alessandro Fraternali, MD, Caterina Mammi, PhD, Annibale Versari, MD

Blood (2011) 118 (21): 5187.

https://doi.org/10.1182/blood.V118.21.5187.5187

Published: 2011

Journal Articles

ATP secreted by endothelial cells blocks CX 3 CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation

Stefania Gorini, Giulia Callegari, Giulia Romagnoli, Caterina Mammi, Domenico Mavilio, Giuseppe Rosano, Massimo Fini, Francesco Di Virgilio, Sara Gulinelli, Simonetta Falzoni, Andrea Cavani, Davide Ferrari, Andrea la Sala

Blood (2010) 116 (22): 4492–4500.

https://doi.org/10.1182/blood-2009-12-260828

Published: 2010

Includes: Supplemental data

Journal Articles

Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results From a Study of the Intergruppo Italiano Linfomi (IIL)

Francesco Merli, MD, Stefano Luminari, MD, Giuseppe Rossi, MD, Caterina Mammi, PhD, Luigi Marcheselli, Dr, Isabel Alvarez, MD, Alessandra Tucci, MD, Caterina Stelitano, MD, Fiorella Ilariucci, MD, Maurizio Musso, MD, Luca Baldini, MD, Alberto Fragasso, MD, Annalisa Chiappella, MD, Massimo Federico, MD

Blood (2010) 116 (21): 1771.

https://doi.org/10.1182/blood.V116.21.1771.1771

Published: 2010

Journal Articles

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study.

Blood (2010) 116 (21): 4613.

https://doi.org/10.1182/blood.V116.21.4613.4613

Published: 2010

Journal Articles

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

Blood (2010) 116 (21): 1360.

https://doi.org/10.1182/blood.V116.21.1360.1360

Published: 2010

Journal Articles

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Francesco Maura, Giovanna Cutrona, PhD, Massimo Gentile, Serena Matis, PhD, Monica Colombo, Luca Agnelli, Giacomo Tuana, Rosanna Massara, Fabrizio Loiacono, Simona Pedemonte, Daniele Reverberi, Emanuela Anna Pesce, Marta Lionetti, PhD, Sonia Fabris, PhD, Anna Grazia Recchia, Francesco Di Raimondo, MD, Caterina Musolino, MD, Marco Gobbi, Nicola Di Renzo, MD, Francesca Romana Mauro, Renato Cantaffa, Maura Brugiatelli, MD, Francesco Merli, MD, Simonetta Zupo, Caterina Mammi, Luca Baldini, Francesco Angrilli, MD, Gianni Quintana, Ugo Consoli, MD, Giovanni Bertoldero, MD, Emilio Iannitto, MD, Paolo Di Tonno, Antonio Fragasso, Stefano Molica, MD, Pellegrino Musto, MD, Maria Cristina Cox, Gianluca Festini, Vincenzo Callea, MD, Stefano Sacchi, Giorgio Lambertenghi Deliliers, MD, Robin Foà, MD, Massimo Federico, MD, Agostino Cortelezzi, MD, Fortunato Morabito, Manlio Ferrarini, Antonino Neri, MD

Blood (2010) 116 (21): 2423.

https://doi.org/10.1182/blood.V116.21.2423.2423

Published: 2010

Journal Articles

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Blood (2009) 114 (22): 2375.

https://doi.org/10.1182/blood.V114.22.2375.2375

Published: 2009

Journal Articles

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Blood (2009) 114 (22): 2341.

https://doi.org/10.1182/blood.V114.22.2341.2341

Published: 2009

Journal Articles

Genome-Wide DNA Copy Number Analysis by SNP Arrays of B-Cell Chronic Lymphocytic Leukemia: Correlation with Known Biological and Molecular Prognostic Markers.

Laura Mosca, PhD, Sonia Fabris, PhD, Giovanna Cutrona, PhD, Luca Agnelli, Serena Matis, PhD, Massimo Gentile, PhD, Mauro Spriano, PhD, Vincenzo Callea, MD, Gianluca Festini, PhD, Stefano Molica, MD, Caterina Mammi, PhD, Massimo Federico, PhD, Giorgio Lambertenghi Deliliers, MD, Fortunato Morabito, MD, Manlio Ferrarini, MD, Antonino Neri, MD

Blood (2008) 112 (11): 1061.

https://doi.org/10.1182/blood.V112.11.1061.1061

Published: 2008

Journal Articles

Incidence Clinical Characteristics and Survival of Non Splenic Marginal Zone Lymphomas: A Population Based Study from a Cancer Registry in Northern Italy

Stefano Luminari, MD, Ivan Rashid, Marina Cesaretti, Luigi Marcheselli, Alessandra Dondi, Stefano Madrigali, Gianluca Cervo, Monica Bellei, Antonella Montanini, Caterina Mammi, Maria Angela Sirotti, Massimo Federico, MD

Blood (2008) 112 (11): 3753.

https://doi.org/10.1182/blood.V112.11.3753.3753

Published: 2008

Journal Articles

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Emilio Iannitto, MD, Stefano Luminari, MD, Caterina Mammi, MD, Viviana Minardi, Francesco Merli, MD, Francesco Angrilli, MD, Caterina Stelitano, MD, Marina Cesaretti, Giovanni Franco, MD, Angelo M. Carella, MD, Massimo Federico, MD

Blood (2007) 110 (11): 1293.

https://doi.org/10.1182/blood.V110.11.1293.1293

Published: 2007

Journal Articles

Incidence, Clinical Characteristics and Survival of Malignant Lymphomas in the Province of Modena (Italy); a Population-Based Study.

Stefano Luminari, Marina Cesaretti, Ivan Rashid, Elsa Pennese, Caterina Mammi, Antonella Montanini, Elisa Barbolini, Monica Bellei, Luigi Marcheselli, Giovanni Partesotti, Alessia Bari, Antonio Maiorana, Tullio Artusi, Massimo Federico

Blood (2006) 108 (11): 4628.

https://doi.org/10.1182/blood.V108.11.4628.4628

Published: 2006

Journal Articles

Response-Based Chemotherapy and Involved Field Radiation for Intermediate Stage Hodgkin Disease. A GISL/NHLSG Trial.

Emilio Iannitto, MD, Viviana Minardi, MD, Paolo G. Gobbi, MD, Giuseppina Calvaruso, MD, Caterina Stelitano, MD, Luca Baldini, MD, Francesco Merli, MD, Mario Petrini, MD, Luigi Marcheselli, Ph.D, Caterina Mammi, Ph.D, Stefano De Cantis, MD, Vincenzo Abbadessa, MD, Massimo Federico, MD

Blood (2006) 108 (11): 2475.

https://doi.org/10.1182/blood.V108.11.2475.2475

Published: 2006

NARROW

Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi

Definition and Validation of the New Elderly Prognostic Index (EPI) for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Geriatric and Clinical Assessment: Results of the Prospective "Elderly Project" on 1353 Patients By the Fondazione Italiana Linfomi

The Elderly Project By the Fondazione Italiana Linfomi (FIL): A Prospective Multidimensional Assessment of Elderly Patients with Diffuse Large B-Cell Lymphoma

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

FDG-PET and Hodgkin Lymphoma: Are We Ready for a Functional Tumor Volume Definition?

ATP secreted by endothelial cells blocks CX 3 CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation

Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results From a Study of the Intergruppo Italiano Linfomi (IIL)

Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included In the Prospective O-CLL1 GISL Study.

Differentiation on Biological Basis of Monoclonal B-Cell Lymphocytosis (MBL) From Chronic Lymphocytic Leukemia (CLL): Results of a Prospective GISL (Gruppo Italiano Studio Linfomi) Trial

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Genome-Wide DNA Copy Number Analysis by SNP Arrays of B-Cell Chronic Lymphocytic Leukemia: Correlation with Known Biological and Molecular Prognostic Markers.

Incidence Clinical Characteristics and Survival of Non Splenic Marginal Zone Lymphomas: A Population Based Study from a Cancer Registry in Northern Italy

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Incidence, Clinical Characteristics and Survival of Malignant Lymphomas in the Province of Modena (Italy); a Population-Based Study.

Response-Based Chemotherapy and Involved Field Radiation for Intermediate Stage Hodgkin Disease. A GISL/NHLSG Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only